Follistatin 344 Research Guide: Myostatin Inhibition and Muscle Hypertrophy Biology
See how this fits the wider landscape of growth-hormone and muscle research peptides.
Follistatin 344 is a research protein whose whole job is to block myostatin, the body’s main “brake” on muscle growth. Take that brake off and muscle can grow far bigger than normal, which is exactly why this myostatin inhibitor is one of the most studied compounds in muscle-growth research.[1]
This article is for research and educational use only. Follistatin 344 is a research compound. It isn’t approved for human use, and nothing here is medical advice.
The “344” part actually matters. The follistatin gene makes two main forms, follistatin 315 and follistatin 344, and the difference is a sticky bit. The 344 form is missing the sticky part that would otherwise glue it to cell surfaces. Because it doesn’t stick, it hangs around in the blood longer and travels through the whole body, which is why researchers reach for the 344 form for whole-body studies. And the effect can be dramatic: in rodent work, putting the follistatin gene straight into muscle has driven gains as big as fully deleting myostatin.
This guide walks through how follistatin 344 blocks myostatin and activin, what rodent studies show on muscle growth, how the 344 and 315 forms differ, how it compares to other muscle peptides, and what to know about dosing, safety, and sourcing.
What is follistatin 344 used for?
Mostly it’s a research tool for studying how myostatin controls muscle. Scientists use it to probe muscle-wasting models like cachexia, sarcopenia, and muscular dystrophy, and to study muscle development without the sprawling, whole-body effects of anabolic steroids. Some studies go a step further and deliver the follistatin gene using a virus, so the muscle keeps churning out the protein on its own. None of this is approved by Health Canada or the FDA for any medical use, and research-grade material is sold strictly for laboratory research.
How does follistatin 344 work?
It works by shutting myostatin down. Myostatin, also called GDF-8, is the protein that tells muscle to stop growing. Hosoyama and colleagues, in the Journal of Reproduction and Development, showed how myostatin in the blood acts on skeletal muscle and reins in early muscle growth, switching on the ActRIIB receptor and the Smad2/3 signals that turn muscle protein-building down.[2]
Follistatin’s move is to grab myostatin out in the blood and keep it from ever reaching that receptor. Lee, in Molecular Endocrinology, described it as a myostatin-binding protein that blocks myostatin activity both in the dish and in living animals.[1] Pull that brake off and muscle protein-building just keeps rolling, so the muscle grows past its usual limit. The 344 form is the stronger one here, precisely because it doesn’t carry the sticky part that traps the 315 form on cell surfaces. It stays in circulation and blocks myostatin body-wide.
Effects on muscle growth and muscle mass
This is where follistatin 344 earns its reputation, since it produces some of the largest gains of any research peptide. Rodino-Klapac and colleagues, in Muscle & Nerve, call it a powerful myostatin inhibitor and a leading candidate for muscle-growth therapy.[3] And Barbé and colleagues, in the American Journal of Physiology, showed the increase in muscle mass comes from two things at once: existing muscle fibers growing larger, and new fibers being added from satellite cells.[4]
The scale depends on how you deliver it. In rodent gene-therapy studies, where a virus keeps the muscle producing follistatin continuously, muscle mass climbed 30 to 50 percent above normal animals. Give the plain protein instead and the gains are smaller but still real, somewhere around 5 to 15 percent over 6 to 12 weeks compared with controls.
Activin inhibition and broader effects
Here’s the catch that makes follistatin more than a one-trick myostatin inhibitor: it also grabs activin A and activin B. Gilson and colleagues, in the American Journal of Physiology, showed the muscle growth comes from satellite-cell activity plus the blocking of both myostatin and activin.[5] Blocking activin does pile on extra muscle, but activin also has day jobs in reproduction, the immune system, and blood-cell production. So follistatin can trigger effects well outside muscle, and that’s something researchers need to watch for.
What is the strongest peptide for gaining muscle?
Per dose, follistatin 344 is the strongest muscle-growth peptide in rodent research, full stop. Its effect outsizes CJC-1295 plus ipamorelin stacks, IGF-1 LR3, MGF, and the rest. The trade-off is twofold: it works by a completely different route than the growth-hormone peptides, blocking myostatin and activin rather than nudging GH, and its reach extends beyond muscle. But if you want pure muscle-growth firepower in the published studies, this is the most powerful tool going.
Follistatin 344 vs anabolic steroids
Both grow muscle, but they get there by opposite logic. Steroids switch on the androgen receptor in muscle and across the whole body, directly pushing protein-building up, and that broad androgen action is what drags along the heart, liver, fertility, and mood side effects. Follistatin 344 does the reverse: instead of pressing the gas, it removes a brake, grabbing myostatin and activin in the blood so the muscle-growth block simply lifts. Its main risk isn’t androgenic at all; it’s the broader activin blocking that touches reproduction and other tissues. And there’s a maturity gap, too, since steroids have been studied for decades while follistatin protein therapy is still relatively new. So the pick comes down to the question. For myostatin biology, follistatin 344 is the right tool. For general muscle growth where any method counts, steroids simply have more human data behind them.
What foods are high in follistatin?
Honestly, none, at least not in any useful amount. The popular “egg yolks are high in follistatin” line traces back to a small study showing a tiny bump in blood follistatin levels after eating egg yolks. That bump is minuscule next to giving follistatin as a drug. Any follistatin in food gets broken down into amino acids in the stomach, so it never reaches the blood as whole protein. Food just can’t match the muscle effects of injected protein or gene therapy.
Gene therapy approaches
The most active follistatin work right now is in gene therapy. Researchers use a harmless AAV virus to deliver the follistatin 344 gene into muscle, so the muscle keeps making the protein for months or even years off a single dose. Early clinical trials in Becker muscular dystrophy and inclusion body myositis reported small gains in muscle function and walking distance. The appeal is obvious, no repeat injections, but it adds its own risks, like off-target effects in other tissues and immune reactions to the virus itself.
Dosing and administration
Research dosing runs the follistatin 344 protein at roughly 100 micrograms up to 5 milligrams per dose, injected under the skin or into muscle, usually two or three times a week. Gene therapy is a different animal, a single AAV injection into muscle at very high virus counts. The plain protein clears the blood within hours, so you have to inject it often to keep it working, and longer-lasting versions are in development.
Side effects and safety
At normal doses, the side effects in research and early trials are small, mostly some injection-site soreness, the rare bout of mild tiredness, and no clear liver or heart warning signs. The risks worth flagging are more about the mechanism. The big one is that broader activin blocking, which reaches reproduction and other tissues. There’s also a theoretical worry about tumor growth in tissues where myostatin or activin normally hold cells in check. And for the gene-therapy route specifically, you add an immune reaction to the virus and the chance of the gene switching on in the wrong tissue. Long-term safety past a few months of steady dosing just isn’t well studied in humans yet.
Is taking follistatin 344 safe?
In rodent and limited human research, it looks safe at normal doses. But it isn’t approved for human use, so “safe” in the legal sense isn’t even defined. Researchers should stick to their lab’s safety rules and keep an eye out for activin-related effects beyond muscle.
Is follistatin 344 approved for medical use?
No. It isn’t approved by Health Canada, the FDA, or the EMA, and although early gene-therapy trials are running in muscular dystrophy, no finished product exists. As a muscle-growing agent it also sits on the World Anti-Doping Agency banned list, so it is handled as a research chemical only; the Canadian legal framework for research peptides covers the rules that apply.
Before you run an experiment, order peptides in Canada and confirm the certificate of analysis up front.
What an unverified batch does to your data
Follistatin 344 is a full protein of roughly 37 to 38 kDa, not a short peptide, and its whole job depends on a correctly folded surface that traps myostatin and activin in the blood. That makes the failure mode sneaky. A lot that is misfolded or partly degraded can still weigh about the right amount on a rough check yet no longer bind its targets, so your muscle-growth readout comes back flat and you blame the biology instead of the reagent. A truncated version missing part of the sequence can also shift how it grabs activin, spilling into the off-target reproductive and blood-cell effects that make follistatin data hard to read. Endotoxin is especially costly here, because it stirs up the same immune and satellite-cell activity you are trying to attribute to myostatin blockade, and a silently under-strength vial just looks like a weak effect. Mass spectrometry confirming the expected weight and identity, HPLC purity from a batch-specific Certificate of Analysis, and endotoxin plus sterility testing for any live-animal or cell-culture work are what keep those artifacts out.[6]
Reviv Peptides supplies research-grade follistatin 344 with third-party COA and HPLC purity confirmation. View the Reviv Peptides shop for current availability.
Follistatin 344 questions
What is follistatin 344 used for?
It’s a research tool for studying myostatin biology, testing muscle-wasting models, and studying muscle growth without the wide effects of steroids. Gene-therapy studies deliver the follistatin gene with a virus for lasting muscle production.
Is taking follistatin 344 safe?
It looks safe in research at normal doses. The possible risks are broader activin blocking and a theoretical tumor-growth worry in tissues where myostatin or activin hold cells back. Long-term human safety isn’t known.
What is the strongest peptide for gaining muscle?
Follistatin 344 delivers the largest muscle gains per dose in rodent research, beating growth-hormone peptides like CJC-1295 plus ipamorelin and beating IGF-1 LR3. The trade-off is its broader effects from blocking activin.
What foods are high in follistatin?
None in a useful amount. The egg-yolk claim is overstated, since follistatin in food is broken down in the gut and never reaches the blood as whole protein. Food can’t match injected protein or gene therapy.
How does follistatin 344 work?
It grabs and blocks myostatin and activin in the blood, stopping their stop-growth signal at the ActRIIB receptor on muscle cells. That removes the brake on muscle protein-building, letting muscle grow larger than normal myostatin levels would ever allow.
Key data point: Lee (2010, Molecular Endocrinology) laid out why follistatin outperforms a pure myostatin block, it neutralises not just myostatin but the activins as well, and taking out several growth-limiting signals at once is what lets follistatin drive bigger increases in muscle mass than removing myostatin alone.[1]
Summary
Follistatin 344 is one of the strongest muscle-targeting research peptides. It works by blocking myostatin and activin, not by boosting growth hormone. The 344 form has no sticky part, so it stays in the blood and blocks myostatin body-wide. Rodent gene therapy shows 30 to 50 percent muscle gains, while the plain protein shows smaller 5 to 15 percent gains. It’s clean for muscle research but reaches into broader activin effects that researchers should track. It stays unapproved and WADA-banned, so it is handled as a research chemical only.
Sources: [1] Follistatin and activins regulate muscle mass (Lee, 2010), PubMed. [2] Serum myostatin limits muscle growth (Hosoyama et al., 2006), PubMed. [3] Follistatin as therapy for muscle disease (Rodino-Klapac et al., 2009), PubMed. [4] Role of IGF-I in follistatin-induced hypertrophy (Barbé et al., 2015), PubMed. [5] Hypertrophy via satellite cells and myostatin/activin inhibition (Gilson et al., 2009), PubMed. [6] HPLC and mass-spectrometry quality control of synthetic peptides, PMC/NIH.
The Reviv Peptides Research Team is a collective of science writers and researchers dedicated to producing evidence-based, peer-reviewed-grade content about research peptides. Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data — including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank). All content is written in a strict preclinical/laboratory context; none of our editorial material is intended as medical advice. Every guide is reviewed for scientific accuracy against published peer-reviewed literature.
Related Posts

Buying Peptides in Canada: Legal Framework & Supplier Criteria
A plain-language guide to the Canadian legal framework around peptides and the supplier criteria researchers should actually verify.

Peptide Reconstitution Guide: Bacteriostatic Water, Dosing & Storage
A laboratory-style guide to reconstituting lyophilized peptides with bacteriostatic water, dosing math, syringe selection, and storage best practices.